CURATEQ BIOLOGICS S.R.O

Italy

All drugs from this manufacturer

  • DAZUBLYS

    It is prescribed for the treatment of breast cancer (early stage or metastatic) and gastric cancer, provided that high levels of a protein called HER2 are present.

    Dosage form: powder for concentrate for infusion solution

    Active substance Dosage
    trastuzumab -

    ATC: L01FD01

  • DYRUPEG

    Dyrupeg is used to reduce the duration of neutropenia (low white blood cell count) and the risk of febrile neutropenia caused by chemotherapy in adults aged 18 years and older. The drug stimulates the bone marrow to produce more white blood cells to help the body fight infections.

    Dosage form: solution for injection in pre-filled syringe

    Active substance Dosage
    pegfilgrastim -

    ATC: L03AA13

  • ZEFYLTI

    Zefylti is used to increase the number of white blood cells in the blood. It is used to prevent infections after chemotherapy or after a bone marrow transplant, before high-dose chemotherapy for stem cell collection, in cases of severe chronic neutropenia, or to reduce the risk of infection in patients with advanced-stage HIV.

    Dosage form: solution for injection, pre-filled syringe

    Active substance Dosage
    filgrastim -

    ATC: L03AA02